Positive cross-regulatory loop ties GATA-3 to estrogen receptor alpha expression in breast cancer - PubMed (original) (raw)
Positive cross-regulatory loop ties GATA-3 to estrogen receptor alpha expression in breast cancer
Jérôme Eeckhoute et al. Cancer Res. 2007.
Abstract
The transcription factor GATA-3 is required for normal mammary gland development, and its expression is highly correlated with estrogen receptor alpha (ER alpha) in human breast tumors. However, the functional role of GATA-3 in ER alpha-positive breast cancers is yet to be established. Here, we show that GATA-3 is required for estradiol stimulation of cell cycle progression in breast cancer cells. The role of GATA-3 in estradiol signaling requires the direct positive regulation of the expression of the ER alpha gene itself by GATA-3. GATA-3 binds to two cis-regulatory elements located within the ER alpha gene, and this is required for RNA polymerase II recruitment to ER alpha promoters. Reciprocally, ER alpha directly stimulates the transcription of the GATA-3 gene, indicating that these two factors are involved in a positive cross-regulatory loop. Moreover, GATA-3 and ER alpha regulate their own expression in breast cancer cells. Hence, this transcriptional coregulatory mechanism accounts for the robust coexpression of GATA-3 and ER alpha in human breast cancers. In addition, these results highlight the crucial role of GATA-3 for the response of ER alpha-positive breast cancers to estradiol. Moreover, they identify GATA-3 as a critical component of the master cell-type-specific transcriptional network including ER alpha and FoxA1 that dictates the phenotype of hormone-dependent breast cancer.
Similar articles
- Cancer-specific mutation of GATA3 disrupts the transcriptional regulatory network governed by Estrogen Receptor alpha, FOXA1 and GATA3.
Takaku M, Grimm SA, De Kumar B, Bennett BD, Wade PA. Takaku M, et al. Nucleic Acids Res. 2020 May 21;48(9):4756-4768. doi: 10.1093/nar/gkaa179. Nucleic Acids Res. 2020. PMID: 32232341 Free PMC article. - A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer.
Eeckhoute J, Carroll JS, Geistlinger TR, Torres-Arzayus MI, Brown M. Eeckhoute J, et al. Genes Dev. 2006 Sep 15;20(18):2513-26. doi: 10.1101/gad.1446006. Genes Dev. 2006. PMID: 16980581 Free PMC article. - Prognosis of hormone-dependent breast cancers: implications of the presence of dysfunctional transcriptional networks activated by insulin via the immune transcription factor T-bet.
McCune K, Bhat-Nakshatri P, Thorat MA, Nephew KP, Badve S, Nakshatri H. McCune K, et al. Cancer Res. 2010 Jan 15;70(2):685-96. doi: 10.1158/0008-5472.CAN-09-1530. Epub 2010 Jan 12. Cancer Res. 2010. PMID: 20068169 Free PMC article. - The estrogen receptor/GATA3/FOXA1 transcriptional network: lessons learned from breast cancer.
Martin EM, Orlando KA, Yokobori K, Wade PA. Martin EM, et al. Curr Opin Struct Biol. 2021 Dec;71:65-70. doi: 10.1016/j.sbi.2021.05.015. Epub 2021 Jul 2. Curr Opin Struct Biol. 2021. PMID: 34225008 Free PMC article. Review. - GATA-3 as a marker of hormone response in breast cancer.
Fang SH, Chen Y, Weigel RJ. Fang SH, et al. J Surg Res. 2009 Dec;157(2):290-5. doi: 10.1016/j.jss.2008.07.015. Epub 2008 Aug 26. J Surg Res. 2009. PMID: 19059610 Review.
Cited by
- Cooperating transcription factors mediate the function of estrogen receptor.
Fiorito E, Katika MR, Hurtado A. Fiorito E, et al. Chromosoma. 2013 Mar;122(1-2):1-12. doi: 10.1007/s00412-012-0392-7. Epub 2012 Nov 29. Chromosoma. 2013. PMID: 23192763 Free PMC article. Review. - The androgen receptor interacts with GATA3 to transcriptionally regulate a luminal epithelial cell phenotype in breast cancer.
Hosseinzadeh L, Kikhtyak Z, Laven-Law G, Pederson SM, Puiu CG, D'Santos CS, Lim E, Carroll JS, Tilley WD, Dwyer AR, Hickey TE. Hosseinzadeh L, et al. Genome Biol. 2024 Feb 5;25(1):44. doi: 10.1186/s13059-023-03161-y. Genome Biol. 2024. PMID: 38317241 Free PMC article. - Cell lineage tracing links ERα loss in Erbb2-positive breast cancers to the arising of a highly aggressive breast cancer subtype.
Ding Y, Liu Y, Lee DK, Tong Z, Yu X, Li Y, Xu Y, Lanz RB, O'Malley BW, Xu J. Ding Y, et al. Proc Natl Acad Sci U S A. 2021 May 25;118(21):e2100673118. doi: 10.1073/pnas.2100673118. Proc Natl Acad Sci U S A. 2021. PMID: 34006643 Free PMC article. - CAXII Is a Surrogate Marker for Luminal Breast Tumors Regulated by ER and GATA3.
Porras L, Gorse F, Thiombane NK, Gaboury L, Mader S. Porras L, et al. Cancers (Basel). 2022 Nov 6;14(21):5453. doi: 10.3390/cancers14215453. Cancers (Basel). 2022. PMID: 36358871 Free PMC article. - Positive Regulation of Estrogen Receptor Alpha in Breast Tumorigenesis.
Porras L, Ismail H, Mader S. Porras L, et al. Cells. 2021 Oct 31;10(11):2966. doi: 10.3390/cells10112966. Cells. 2021. PMID: 34831189 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical